MiR-375-mediated suppression of engineered coxsackievirus B3 in pancreatic cells
Publikation: Beitrag in Fachzeitschrift › Forschungsartikel › Beigetragen › Begutachtung
Beitragende
Abstract
Coxsackievirus B3 (CVB3) has potential as a new oncolytic agent for the treatment of cancer but can induce severe pancreatitis. Here, we inserted target sequences of the microRNA miR-375 (miR-375TS) into the 5′ terminus of the polyprotein encoding sequence or into the 3′UTR of the CVB3 strain rCVB3.1 to prevent viral replication in the pancreas. In pancreatic EndoC-βH1 cells expressing miR-375 endogenously, replication of the 5′-miR-375TS virus and that of the 3′-miR-375TS virus was reduced by 4 × 103-fold and 3.9 × 104-fold, respectively, compared to the parental rCVB3.1. In colorectal carcinoma cells, replication and cytotoxicity of both viruses were slightly reduced compared to rCVB3.1, but less pronounced for the 3′-miR-375TS virus. Thus, CVB3 with miR-375TS in the 3′UTR of the viral genome may be suitable to avoid pancreatic toxicity.
Details
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 763-775 |
Seitenumfang | 13 |
Fachzeitschrift | FEBS letters |
Jahrgang | 594 |
Ausgabenummer | 4 |
Publikationsstatus | Veröffentlicht - 1 Feb. 2020 |
Peer-Review-Status | Ja |
Externe IDs
PubMed | 31643074 |
---|
Schlagworte
Ziele für nachhaltige Entwicklung
ASJC Scopus Sachgebiete
Schlagwörter
- cancer therapy, colorectal cancer, coxsackievirus B3, microRNA, oncolytic virus